Vikas Kumar
Impact in
- Drug Discovery top 0.2%
- Pharmaceutical Science top 1%
- Advancements in Transdermal Drug Delivery
Papers in
- Biomaterials 28
- Nanoparticle-Based Drug Delivery 27
-
- Advancements in Transdermal Drug Delivery 14
- Co-authors
- Fahad Ahmed Al-Abbasi (51 shared papers)Amita Verma (45 shared papers)Firoz Anwar (36 shared papers)Mahfoozur Rahman (44 shared papers)Firoz Anwar (25 shared papers)Mohammad Amjad Kamal (7 shared papers)Sergey Levine (2 shared papers)Tony Z. Zhao (1 shared paper)
- Journals
- Inflammopharmacology (9 papers)Biocatalysis and Agricultural Biotechnology (7 papers)Biomedicine & Pharmacotherapy (6 papers)International Journal of Nanomedicine (4 papers)RSC Advances (4 papers)
- Partner nations
- IndiaSaudi ArabiaUnited States
In The Last Decade
Vikas Kumar
231 papers receiving 4.4k citations
Vikas Kumar's Hit Papers
Peers
Comparison fields: 5 of 157
- Drug Discovery 79
- Pharmaceutical Science 322
- Biomaterials 558
- Complementary and alternative medicine 184
- Pharmacology 245
Countries citing papers authored by Vikas Kumar
This map shows the geographic impact of Vikas Kumar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vikas Kumar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vikas Kumar more than expected).
Fields of papers citing papers by Vikas Kumar
This network shows the impact of papers produced by Vikas Kumar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vikas Kumar. The network helps show where Vikas Kumar may publish in the future.
Co-authors
The 25 scholars most cited alongside Vikas Kumar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 259 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Learning Fine-Grained Bimanual Manipulation with Low-Cost Hardware Hit paper breakdown → | 2023 | 338 |
| 2 | 2019 | 205 | |
| 3 | Micro- and nano-plastics (MNPs) as emerging pollutant in ground water: Environmental impact, potential risks, limitations and way forward towards sustainable management Hit paper breakdown → | 2023 | 163 |
| 4 | 2020 | 119 | |
| 5 | 2019 | 106 | |
| 6 | 2018 | 102 | |
| 7 | 2011 | 98 | |
| 8 | 2012 | 95 | |
| 9 | 2019 | 76 | |
| 10 | 2017 | 75 | |
| 11 | 2017 | 71 | |
| 12 | 2021 | 68 | |
| 13 | 2008 | 65 | |
| 14 | 2014 | 65 | |
| 15 | 2024 | 63 | |
| 16 | 2013 | 60 | |
| 17 | 2017 | 60 | |
| 18 | 2016 | 59 | |
| 19 | 2017 | 59 | |
| 20 | Photoperiodism in higher vertebrates: an adaptive strategy in temporal environment. | 1997 | 58 |
About Vikas Kumar
Vikas Kumar is a scholar working on Biomaterials, Pharmaceutical Science, Plant Science, Complementary and alternative medicine and Organic Chemistry, having authored 259 papers that have together received 4.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (27 papers), Advancements in Transdermal Drug Delivery (14 papers), Natural Antidiabetic Agents Studies (12 papers), Medicinal Plant Research (11 papers), Cancer and biochemical research (10 papers), Synthesis and Characterization of Heterocyclic Compounds (9 papers), Nanoparticles: synthesis and applications (9 papers) and Asymmetric Synthesis and Catalysis (8 papers). The work is most often cited by research in Drug Discovery (79 citations), Pharmaceutical Science (322 citations), Biomaterials (558 citations), Complementary and alternative medicine (184 citations) and Pharmacology (245 citations). Vikas Kumar has collaborated with scholars based in India, Saudi Arabia and United States. Frequent co-authors include Fahad Ahmed Al-Abbasi, Amita Verma, Firoz Anwar, Mahfoozur Rahman, Firoz Anwar, Mohammad Amjad Kamal, Sergey Levine, Tony Z. Zhao, Chelsea Finn and Prakash Chandra Bhatt. Their work appears in journals such as Inflammopharmacology, Biocatalysis and Agricultural Biotechnology, Biomedicine & Pharmacotherapy, International Journal of Nanomedicine and RSC Advances.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.